Case Study

MAA SUPPORT AND LEADERSHIP: US TO EU

MAA SUPPORT AND LEADERSHIP: US TO EU

Suite 2, Ground Floor, Field House, Station Approach, Harlow, Essex CM20 2FB T +44 (0)203 911 9410 F +44 (0)1279 418 964 diamondpharmaservices.com HOW DIAMOND MAKES A DIFFERENCE Proactive strategic advice Proactive interactions with regulators and clients Diligent operational support A true desire, alongside our client, to be the first, e.g.: • Supported the first gene-therapy approval in Europe • Supported the first CAR T-cell therapy in Europe • Supported the first treatment for the rare disease, familial chylomicronaemia syndrome, in Europe MAA SUPPORT AND LEADERSHIP: US TO EU At Diamond, we have been successful in supporting US clients to transition their late stage clinical development programmes through to Marketing Authorisation Application (MAA) in the European U

Join for free to read